Completed
A Study of Gaboxadol in Primary Insomnia
NCT00209963
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
Not specified
Clinical trial condition
Sleep Wake Disorders
Explore clinical trials studying Sleep Wake Disorders. Study availability and eligibility vary by location and protocol.
5,115 public trials
775 recruiting studies
Sleep Wake Disorders trial results
Completed
A Study of Gaboxadol in Primary Insomnia
NCT00209924
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Non-US study, principal location: Gothenburg, Sweden
Completed
Sleep Quality in CHIMES (MF101)
NCT00454441
- Conditions
- Dyssomnias, Menopausal Symptoms, Mental Disorders, +5 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- University of Minnesota Twin Cities Campus Minneapolis, Minnesota, United States
NCT00209937
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
Not specified
NCT00209950
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Non-US study, principal location: Regensburg, Germany
Completed
Effects of Sleep Loss on Endothelial Function and Cytokine Levels in Internal Medicine Residents
NCT00272233
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +5 more
- Locations
-
- Yale University School of Medicine New Haven, Connecticut, United States
NCT00259311
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anaheim, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burbank, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
NCT00400543
- Conditions
- Apnea, Arterial Occlusive Diseases, Arteriosclerosis, +13 more
- Locations
-
- Heart Institute (InCor) - University of São Paulo Medical School São Paulo, Brazil
Completed
Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder
NCT00385437
- Conditions
- Behavior, Behavioral Symptoms, Depression, +10 more
- Locations
-
- University Health Network Toronto, Ontario, Canada
NCT00243139
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +8 more
- Locations
-
- Nykoebing Falster County Hospital Nykoebing Falster, Storstrøms County, Denmark